MedTrace Logo

Incidence of Allergic Manifestations and Infectious Episodes in Healthy Term Infants at Risk for Dysbiosis

NCT04182425 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 334

Last updated 2023-03-13

No results posted yet for this study

Summary

This study will evaluate the incidence of allergic manifestations (the first of which is atopic dermatitis) and infectious diseases in children fed with an infant formula under real conditions of use.

Conditions

Interventions

OTHER

Infant formula

Healthy full-term infants fed on an infant formula marketed on the French market

Sponsors & Collaborators

  • Bledina

    lead INDUSTRY

Principal Investigators

  • Florence MD CAMPEOTTO · Scientific Committee

  • Hugues MD PILOQUET · Scientific Committee

  • Alexis MD MOSCA · Scientific Committee

  • Olivier MD GOULET · Scientific Committee

  • Marie-José MD BUTEL · Scientific Committee

  • Anne-Judith MD WALIGORA · Scientific Committee

Eligibility

Max Age
5 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-07
Primary Completion
2022-07-04
Completion
2022-07-04

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04182425 on ClinicalTrials.gov